We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

FDA Approval for Genentech’s Subcutaneous Rituximab

News   Mar 31, 2017 | Original Story from Genentech

 
FDA Approval for Genentech’s Subcutaneous Rituximab
 
 
 

RELATED ARTICLES

Glioblastoma Overcomes Treatment Resistance in Promising Preclinical Study

News

A novel method of overcoming treatment resistance to both PD-1 and adoptive cellular therapy has been identified, by employing a concomitant hematopoietic stem and progenitor cell transfer.

READ MORE

New Approach for Controlling Dengue Fever and Zika virus

News

Gene-editing tool to disrupt serotonin receptor linked to egg production in Aedes aegypti mosquitoes.

READ MORE

Proactive Approach Protects Population From HIV

News

A preventative approach to HIV drastically reduced the number of HIV diagnoses in New South Wales, Australia.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE